arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Liquidia Corporation

LQDA Health Care Biotechnology: Pharmaceutical Preparations
$68.66
Today
as of Sep 4, 16:51 ET
Last 30 days -18.67% Jul 27 → Sep 04
$64.98 $71.98 $78.97 $85.96 $92.96 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$67.91
High
$69.47
Low
$67.40
Volume
$897,237
Avg Vol
$2M
Mkt Cap
$6.4B
P/E (TTM)
55.48
Beta
52w High
$93.61
52w Low
$21.15
Div Yield
Shares Out
$89M

Recent Press Releases & News last 60 days · 25 items

▸ Show all 25 press releases & news Free account →

Overview

52-week range
$21
$94
66% of range
Avg surprise (last 3)
+10.6%
Avg reaction (last 2)
+12.2%
50% positive
Latest IV / EM
141%
EM ±5.9% · $69 · Sep 4

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.49$-0.18$0.12$0.43$0.74 Actual $-0.38Actual $-0.40Actual $-0.45Est $-0.42Actual $-0.49Est $-0.43Actual $-0.04Actual $0.52Est $0.34Actual $0.74 JunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-42M$14M$69M$125M$180M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.74 financials
Mon May 11, 2026Mar/2026 $0.52 $0.34 +52.9% +215.6% +25.6% earnings
Tue Sep 30, 2025Sep 2025 $-0.04 financials
Tue Aug 12, 2025Jun/2025 $-0.49 $-0.43 -13.9% earnings
Thu May 8, 2025Mar/2025 $-0.45 $-0.42 -7.1% -1.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.40 financials
Sun Jun 30, 2024Jun 2024 $-0.38 financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$172M$133M$54M$9M$3M$4M
Cost of revenue$2M$2M
Gross profit
Operating income$86M$62M$2M$-38M$-35M$-29M
Net income$75M$53M$-4M$-42M$-38M$-31M
EPS (diluted)$0.74$0.52$-0.04$-0.49$-0.45$-0.40

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$284M$223M$191M$157M$173M$170M$176M$204M
Inventory$36M$29M$24M$25M$6M$1M$241,000$38,000
Total current assets$438M$333M$273M$227M$196M$177M$185M$214M
Total assets$522M$402M$328M$276M$257M$227M$230M$253M
Long-term debt
Total liabilities$327M$293M$283M$254M$242M$178M$151M
Total equity$195M$109M$45M$22M$15M$50M$79M$113M

Implied volatility — last 90 days

66%98%129%160%191% Jun 07 — IV 137% · EM ±12.8%Jun 08 — IV 126% · EM ±10.5%Jun 09 — IV 130% · EM ±9.4%Jun 10 — IV 141% · EM ±8.3%Jun 11 — IV 125% · EM ±5.2%Jun 15 — IV 122% · EM ±8.8%Jun 16 — IV 120% · EM ±7.1%Jun 17 — IV 129% · EM ±5.4%Jun 19 — IV 94% · EM ±10.3%Jun 22 — IV 85% · EM ±7.1%Jun 23 — IV 97% · EM ±7.0%Jun 24 — IV 96% · EM ±5.7%Jun 25 — IV 79% · EM ±3.3%Jun 29 — IV 93% · EM ±22.0%Jun 30 — IV 90% · EM ±20.9%Jul 01 — IV 98% · EM ±4.1%Jul 03 — IV 82% · EM ±9.1%Jul 06 — IV 86% · EM ±7.2%Jul 07 — IV 87% · EM ±6.3%Jul 08 — IV 87% · EM ±5.1%Jul 09 — IV 78% · EM ±3.3%Jul 13 — IV 90% · EM ±7.5%Jul 14 — IV 97% · EM ±7.0%Jul 15 — IV 109% · EM ±6.4%Jul 16 — IV 161% · EM ±6.7%Jul 20 — IV 105% · EM ±8.7%Jul 21 — IV 94% · EM ±6.8%Jul 22 — IV 122% · EM ±7.2%Jul 23 — IV 82% · EM ±3.4%Jul 27 — IV 104% · EM ±8.6%Jul 28 — IV 67% · EM ±4.8%Jul 29 — IV 89% · EM ±5.2%Jul 30 — IV 103% · EM ±4.3%Aug 03 — IV 123% · EM ±17.0%Aug 04 — IV 122% · EM ±16.1%Aug 05 — IV 113% · EM ±14.1%Aug 06 — IV 123% · EM ±14.5%Aug 07 — IV 130% · EM ±14.3%Aug 10 — IV 151% · EM ±12.6%Aug 11 — IV 192% · EM ±13.9%Aug 12 — IV 121% · EM ±7.2%Aug 13 — IV 152% · EM ±6.3%Aug 17 — IV 127% · EM ±10.6%Aug 18 — IV 119% · EM ±8.6%Aug 19 — IV 129% · EM ±7.6%Aug 20 — IV 128% · EM ±5.3%Aug 24 — IV 118% · EM ±9.8%Aug 25 — IV 112% · EM ±8.1%Aug 26 — IV 101% · EM ±6.0%Aug 27 — IV 76% · EM ±3.2%Aug 31 — IV 151% · EM ±12.7%Sep 01 — IV 154% · EM ±11.2%Sep 02 — IV 125% · EM ±7.4%Sep 03 — IV 141% · EM ±5.9%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.